Many with work-related asthma not getting key vaccine

September 27, 2017

(HealthDay)—Only half of American adults with work-related asthma get the recommended vaccination against pneumococcal disease, a new study finds.

Adults with asthma are at increased risk for pneumococcal disease, and the U.S. Centers for Disease Control and Prevention recommends that all adults aged 19 to 64 get the pneumococcal vaccine.

However, an analysis of 2012-13 national data found that only 54 percent of adults with work-related asthma got the shot.

The rate was lowest among Hispanics (36 percent), people without health insurance (39 percent), and adults aged 18 to 44 (42 percent).

The vaccination rate was even lower (35 percent) among adults with non-work-related asthma, according to the study by researchers at the CDC's National Institute for Occupational Safety and Health (NIOSH).

"Vaccination is the best way to prevent pneumococcal disease, including pneumonia, and CDC recommends that all adults with asthma, whether work-related or not, get the pneumococcal polysaccharide vaccine," NIOSH Director Dr. John Howard said in a CDC news release.

Each year, about 900,000 Americans get pneumococcal pneumonia, and 5 percent to 7 percent die from it, the CDC estimates. Adults with asthma who get pneumococcal pneumonia, a lung disease, are at risk for such complications as asthma exacerbation and .

Pneumococcal disease, an infection caused by Streptococcus pneumoniae, can cause many types of illnesses, including ear infections and meningitis.

"To increase the number of with asthma who are vaccinated against , we recommend that verify if their patients who have have received a and offer the vaccine to those not vaccinated," lead author Katelynn Dodd, an epidemiologist at NIOSH, said in the news release.

The findings were published Sept. 27 in the American Journal of Preventive Medicine.

Explore further: CDC finds vaccination coverage varies for adults with diabetes

More information: The U.S. Centers for Disease Control and Prevention has more on pneumococcal disease.

Related Stories

CDC finds vaccination coverage varies for adults with diabetes

December 12, 2016
(HealthDay)—Among adults with diagnosed diabetes, vaccination coverage varies, with influenza vaccination more prevalent than pneumococcal or hepatitis B vaccination, according to a December data brief published by the ...

Team publishes longitudinal work on pneumonia

July 10, 2017
A Marshall University Joan C. Edwards School of Medicine research team has published findings that show patients who recover from invasive pneumococcal pneumonia, on average, live 10 years less when measured against life ...

Seniors need two pneumonia vaccines, CDC advisory panel says

February 3, 2015
(HealthDay)—Adults 65 and older need two vaccines to better protect them from bacterial infection in the blood (called sepsis), meningitis and pneumonia, according to a revised vaccination schedule from the 2015 Advisory ...

Increased risk of pneumococcal pneumonia with hospital admission during school holidays

September 5, 2016
A study presented today (6 September 2016) at this year's European Respiratory Society (ERS) International Congress in London, UK shows that adults admitted to hospital during school holidays are 38% more likely to have pneumococcal ...

Nurses crucial in improving uptake of potentially life-saving vaccine in vulnerable RMD patients

June 15, 2017
The results of a study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference showed that implementing a vaccination programme run by nursing staff dramatically improves pneumococcal ...

Recommended for you

Immune signature predicts asthma susceptibility

February 16, 2018
Asthma is a chronic inflammatory disease driven by the interplay of genetics, environmental factors and a diverse cast of immune cells. In their latest study, researchers at La Jolla Institute for Allergy and Immunology (LJI) ...

Scientists identify immune cascade that fuels complications, tissue damage in chlamydia infections

February 13, 2018
Closing a critical gap in knowledge, Harvard Medical School scientists have unraveled the immune cascade that fuels tissue damage and disease development in chlamydia infection—the most common sexually transmitted disease ...

Mouse study adds to evidence linking gut bacteria and obesity

February 12, 2018
A new Johns Hopkins study of mice with the rodent equivalent of metabolic syndrome has added to evidence that the intestinal microbiome—a "garden" of bacterial, viral and fungal genes—plays a substantial role in the development ...

Cancer killing clue could lead to safer and more powerful immunotherapies

February 12, 2018
New research could help to safely adapt a new immunotherapy—currently only effective in blood cancers—for the treatment of solid cancers, such as notoriously hard-to-treat brain tumours.

Mechanism behind autoimmune disorder revealed

February 7, 2018
Northwestern Medicine scientists discovered a previously-unknown mechanism of disease behind a specific autoimmune disorder, findings published in the Proceedings of the National Academy of Sciences.

Study shows how body prevents potentially useful bacteria from causing disease

February 7, 2018
A new study reveals a mechanism by which the immune system may decide whether a bacterial species is a partner in bodily processes or an invader worthy of attack.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.